Search

everythinglearnresearchcommunity

for

Search:↓

Trichotillomania involves hair pulling and can be treated with therapy and medication.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

People undergoing chemotherapy need better support and information to cope with hair loss.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The reviews critique three psychology books, noting skepticism about a personality inventory for teens, praising a practical guide on body image issues, and recommending a book on grief therapy.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Adrenal disorders can cause lasting brain and behavior issues in children.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.